Minokine

N/A

Report date: 2025/01/26 17:18:16
NME

Base Information

Drug NameMinokine
Drug Alias Namep38 MAP kinase alpha inhibitor (northwestern university)MW01-2-069A-SRM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitorsCytokines modulators
TargetsCytokinesP38 α mitogen-activated protein kinase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A